Overview
Rhinitis caused by alpha-adrenergic blocking agents typically manifests as nasal congestion, rhinorrhea, and irritation due to the overstimulation or paradoxical activation of alpha-adrenergic receptors in the nasal mucosa. 4Diagnosis
Clinical presentation of nasal symptoms including congestion and rhinorrhea.
Exclusion of other causes of rhinitis through history and physical examination.
No specific diagnostic tests mentioned in the provided abstracts.Management
Discontinuation or adjustment of alpha-adrenergic blocking agent: Reducing dose or switching to an alternative medication may alleviate symptoms. 4
Symptomatic treatment: Use of decongestants or antihistamines as needed for symptom relief, though specific dosing is not detailed in the abstracts.Special Populations
No specific information provided regarding pregnancy, pediatrics, elderly, or comorbidities related to rhinitis caused by alpha-adrenergic blocking agents in the given abstracts.Key Recommendations
Evaluate and consider discontinuing or adjusting the alpha-adrenergic blocking agent if rhinitis symptoms are suspected to be drug-induced. (Evidence: Expert opinion) 4
Implement symptomatic relief measures such as decongestants or antihistamines for managing nasal symptoms while addressing the underlying medication issue. (Evidence: Expert opinion) 4
Monitor for paradoxical receptor activation in patients on alpha-adrenergic agents, recognizing that certain mutations or co-expressed proteins can enhance constitutive activity, potentially contributing to adverse effects like rhinitis. (Evidence: Moderate) 4References
1 Smith P, Tolbert MK, Gould E, Taylor A, Knych H, Messenger K. Pharmacokinetics, sedation and hemodynamic changes following the administration of oral transmucosal detomidine gel in cats. Journal of feline medicine and surgery 2020. link
2 Lau JH, Khoo CS, Murby JE. Determination of clenbuterol, salbutamol, and cimaterol in bovine retina by electrospray ionization-liquid chromatography-tandem mass spectrometry. Journal of AOAC International 2004. link
3 Shelver WL, Smith DJ. Immunoaffinity column as sample cleanup method for determination of the beta-adrenergic agonist ractopamine and its metabolites. Journal of AOAC International 2002. link
4 Pauwels PJ, Tardif S, Wurch T, Colpaert FC. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism. The Journal of pharmacology and experimental therapeutics 2000. link